Schroder Investment Management Group boosted its position in Humana Inc. (NYSE:HUM) by 70.8% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 58,792 shares of the insurance provider’s stock after acquiring an additional 24,367 shares during the period. Schroder Investment Management Group’s holdings in Humana were worth $14,071,000 at the end of the most recent reporting period.
A number of other hedge funds have also recently added to or reduced their stakes in HUM. BlackRock Inc. grew its stake in Humana by 2,281.7% in the 1st quarter. BlackRock Inc. now owns 12,387,144 shares of the insurance provider’s stock worth $2,553,487,000 after acquiring an additional 11,867,056 shares during the period. FMR LLC grew its stake in Humana by 57.9% in the 1st quarter. FMR LLC now owns 5,050,853 shares of the insurance provider’s stock worth $1,041,184,000 after acquiring an additional 1,851,197 shares during the period. Renaissance Technologies LLC grew its stake in Humana by 84.3% in the 1st quarter. Renaissance Technologies LLC now owns 2,691,700 shares of the insurance provider’s stock worth $554,867,000 after acquiring an additional 1,231,400 shares during the period. Wellington Management Group LLP grew its stake in Humana by 2,651.1% in the 1st quarter. Wellington Management Group LLP now owns 775,755 shares of the insurance provider’s stock worth $159,915,000 after acquiring an additional 747,557 shares during the period. Finally, AQR Capital Management LLC grew its stake in Humana by 413.8% in the 1st quarter. AQR Capital Management LLC now owns 736,019 shares of the insurance provider’s stock worth $151,723,000 after acquiring an additional 592,772 shares during the period. 95.14% of the stock is owned by hedge funds and other institutional investors.
Humana Inc. (NYSE:HUM) opened at 250.70 on Friday. The firm has a market cap of $36.23 billion, a price-to-earnings ratio of 20.62 and a beta of 0.87. Humana Inc. has a 12-month low of $163.50 and a 12-month high of $259.76. The company’s 50 day moving average is $249.78 and its 200 day moving average is $231.21.
Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, August 2nd. The insurance provider reported $3.49 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $3.08 by $0.41. Humana had a net margin of 3.37% and a return on equity of 15.85%. The company had revenue of $13.53 billion for the quarter, compared to analyst estimates of $13.61 billion. During the same quarter in the prior year, the business posted $2.30 EPS. On average, equities analysts anticipate that Humana Inc. will post $11.55 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Stockholders of record on Tuesday, August 29th will be paid a dividend of $0.40 per share. The ex-dividend date is Thursday, September 28th. This represents a $1.60 annualized dividend and a dividend yield of 0.64%. Humana’s dividend payout ratio (DPR) is 13.06%.
Several research firms have commented on HUM. Zacks Investment Research raised shares of Humana from a “hold” rating to a “buy” rating and set a $255.00 target price for the company in a research note on Tuesday, June 13th. BidaskClub cut shares of Humana from a “buy” rating to a “hold” rating in a research note on Tuesday, June 13th. Citigroup Inc. began coverage on shares of Humana in a research note on Wednesday, June 28th. They issued a “buy” rating and a $275.00 target price for the company. Credit Suisse Group reaffirmed an “outperform” rating and issued a $260.00 target price (up from $250.00) on shares of Humana in a research note on Thursday, August 3rd. Finally, Deutsche Bank AG lifted their target price on shares of Humana from $234.00 to $243.00 and gave the stock a “hold” rating in a research note on Monday, August 7th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average target price of $244.35.
COPYRIGHT VIOLATION WARNING: “Humana Inc. (HUM) Holdings Increased by Schroder Investment Management Group” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://ledgergazette.com/2017/09/15/humana-inc-hum-holdings-increased-by-schroder-investment-management-group.html.
In other news, SVP Brian P. Leclaire sold 4,971 shares of the stock in a transaction on Wednesday, June 28th. The shares were sold at an average price of $240.00, for a total transaction of $1,193,040.00. Following the transaction, the senior vice president now owns 14,258 shares in the company, valued at approximately $3,421,920. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CEO Bruce D. Broussard sold 12,000 shares of the stock in a transaction on Friday, August 11th. The stock was sold at an average price of $251.88, for a total transaction of $3,022,560.00. Following the transaction, the chief executive officer now owns 80,086 shares in the company, valued at approximately $20,172,061.68. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 60,566 shares of company stock worth $15,326,746. 0.80% of the stock is currently owned by company insiders.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Humana Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.